Maroof Alam

Dr. Maroof Alam

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2021 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MLMing Liu
Ming Liu
YHYumeng Huang
Yumeng Huang
XXXiaoxi Xu
Xiaoxi Xu
XLXin Li
Xin Li
MAMaroof Alam
Maroof Alam
PAPeter Arvan
Peter Arvan
Both basal and glucose-stimulated insulin release occur primarily by insulin secretory granule exocytosis from pancreatic β cells, and both are needed to maintain normoglycemia. Loss of insulin-secreting β cells, accompanied by abnormal glucose tolerance, may involve simple exhaustion of insulin reserves (which, by immunostaining, appears as a loss of β cell identity), or β cell dedifferentiation, or β cell death. While various sensing and signaling defects can result in diminished insulin secretion, somewhat less attention has been paid to diabetes risk caused by insufficiency in the biosynthetic generation and maintenance of the total insulin granule storage pool. This Review offers an overview of insulin biosynthesis, beginning with the preproinsulin mRNA (translation and translocation into the ER), proinsulin folding and export from the ER, and delivery via the Golgi complex to secretory granules for conversion to insulin and ultimate hormone storage. All of these steps are needed for generation and maintenance of the total insulin granule pool, and defects in any of these steps may, weakly or strongly, perturb glycemic control. The foregoing considerations have obvious potential relevance to the pathogenesis of type 2 diabetes and some forms of monogenic diabetes; conceivably, several of these concepts might also have implications for β cell failure in type 1 diabetes.

19 May 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
XXXiaoxi Xu
Xiaoxi Xu
Anoop ArunagiriAnoop Arunagiri
Anoop Arunagiri
MAMaroof Alam
Maroof Alam
LHLeena Haataja
Leena Haataja
CECharles Evans
Charles Evans
PAPeter Arvan
Peter Arvan
Insulin is made from proinsulin, but the extent to which fasting/feeding controls the homeostatically regulated proinsulin pool in pancreatic β-cells remains largely unknown. Here, we first examined β-cell lines (INS1E and Min6, which proliferate slowly and are routinely fed fresh medium every 2-3 days) and found that the proinsulin pool size responds to each feeding within 1 to 2 h, affected both by the quantity of fresh nutrients and the frequency with which they are provided. We observed no effect of nutrient feeding on the overall rate of proinsulin turnover as quantified from cycloheximide-chase experiments. We show that nutrient feeding is primarily linked to rapid dephosphorylation of translation initiation factor eIF2α, presaging increased proinsulin levels (and thereafter, insulin levels), followed by its rephosphorylation during the ensuing hours that correspond to a fall in proinsulin levels. The decline of proinsulin levels is blunted by the integrated stress response inhibitor, ISRIB, or by inhibition of eIF2α rephosphorylation with a general control nonderepressible 2 (not PERK) kinase inhibitor. In addition, we demonstrate that amino acids contribute importantly to the proinsulin pool; mass spectrometry shows that β-cells avidly consume extracellular glutamine, serine, and cysteine. Finally, we show that in both rodent and human pancreatic islets, fresh nutrient availability dynamically increases preproinsulin, which can be quantified without pulse-labeling. Thus, the proinsulin available for insulin biosynthesis is rhythmically controlled by fasting/feeding cycles.

19 August 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
XXXiaoxi Xu
Xiaoxi Xu
Anoop ArunagiriAnoop Arunagiri
Anoop Arunagiri
LHLeena Haataja
Leena Haataja
MAMaroof Alam
Maroof Alam
SJShuhui Ji
Shuhui Ji
PAPeter Arvan
Peter Arvan
Preproinsulin entry into the endoplasmic reticulum yields proinsulin, and its subsequent delivery to the distal secretory pathway leads to processing, storage, and secretion of mature insulin. Multiple groups have reported that treatment of pancreatic beta cell lines, rodent pancreatic islets, or human islets with proteasome inhibitors leads to diminished proinsulin and insulin protein levels, diminished glucose-stimulated insulin secretion, and changes in beta-cell gene expression that ultimately lead to beta-cell death. However, these studies have mostly examined treatment times far beyond that needed to achieve acute proteasomal inhibition. Here, we report that although proteasomal inhibition immediately downregulates new proinsulin biosynthesis, it nevertheless acutely increases beta-cell proinsulin levels in pancreatic beta cell lines, rodent pancreatic islets, and human islets, indicating rescue of a pool of recently synthesized WT INS gene product that would otherwise be routed to proteasomal disposal. Our pharmacological evidence suggests that this disposal most likely reflects ongoing endoplasmic reticulum–associated protein degradation. However, we found that within 60 min after proteasomal inhibition, intracellular proinsulin levels begin to fall in conjunction with increased phosphorylation of eukaryotic initiation factor 2 alpha, which can be inhibited by blocking the general control nonderepressible 2 kinase. Together, these data demonstrate that a meaningful subfraction of newly synthesized INS gene product undergoes rapid proteasomal disposal. We propose that free amino acids derived from proteasomal proteolysis may potentially participate in suppressing general control nonderepressible 2 kinase activity to maintain ongoing proinsulin biosynthesis.

12 January 2023 in ACS Pharmacology & Translational Science
Verified
Journal Article
Closed access
AGAmit Garg
Amit Garg
MAMaroof Alam
Maroof Alam
SBShakuntala Bai
Shakuntala Bai
MDMonica Dandawate
Monica Dandawate
NKNeeta Kumari
Neeta Kumari
AMArnab Mukhopadhyay
Arnab Mukhopadhyay

18 November 2025 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Anoop ArunagiriAnoop Arunagiri
Anoop Arunagiri
LHLeena Haataja
Leena Haataja
MAMaroof Alam
Maroof Alam
NGNoah Gleason
Noah Gleason
EMEmma Mastroianni
Emma Mastroianni
PAPeter Arvan
Peter Arvan
In pancreatic β cells, misfolded proinsulin is a substrate for ER-associated protein degradation (ERAD) via HRD1/SEL1L. Alternately, β cell HRD1 activity is reported to improve, or impair, insulin biogenesis. Further, while β cell SEL1L deficiency causes HRD1 hypofunction and diminishes islet insulin content, reports conflict as to whether β cell ERAD deficiency increases or decreases proinsulin levels. Here, we examined β cell–specific Hrd1 -KO mice (chronic deficiency) and rodent (and human islet) β cells treated acutely with HRD1 inhibitor. β -Hrd1 –KO mice developed diabetes with decreased islet proinsulin, yet a relative increase of misfolded proinsulin redistributed to the ER. They also showed upregulated biochemical markers of β cell ER stress and autophagy, electron microscopy evidence of ER enlargement and decreased insulin granule content, and increased glucagon-positive islet cells. Misfolded proinsulin was also increased in islets treated with inhibitors of lysosomal degradation. Preceding any loss of total proinsulin, acute HRD1 inhibition triggered increased nonnative proinsulin, increased phospho-eIF2α with inhibited proinsulin synthesis, and increased LC3b-II (the abundance of which requires expression of ΣR1). We posit a subset of proinsulin molecules undergo HRD1-mediated disposal. When HRD1 is unavailable, misfolded proinsulin accumulates, accompanied by increased phospho-eIF2α that limits further proinsulin synthesis, plus ΣR1-dependent autophagy activation, ultimately lowering steady-state β cell proinsulin (and insulin) levels and triggering diabetes.

18 June 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
Anoop ArunagiriAnoop Arunagiri
Anoop Arunagiri
MAMaroof Alam
Maroof Alam
EDErez Dror
Erez Dror
Melkam Alamerew KebedeMelkam Alamerew Kebede
Melkam Alamerew Kebede
This editorial introduces a Research Topic exploring the diverse relationships between diet, 17 metabolism, and health. The collection of eight studies examines topics ranging from dietary trends 18 and obesity to the impact of specific nutrients and ultra-processed foods on metabolic health and 19 quality of life. Investigations into the effects of low-carbohydrate diets on metabolic syndrome, the 20 link between thyroid hormone sensitivity and insulin resistance, and the prevalence of anemia in 21 pregnant women are presented. Furthermore, the relationship between dietary nitrates/nitrites and gut 22 metabolites in metabolic syndrome, and the weight-loss-independent effects of fasting on human 23 growth hormone are highlighted. Collectively, these studies underscore the multifaceted nature of 24 nutritional science and offer valuable insights for future research and public health strategies aimed at 25 improving health outcomes. 26The complex connection between diet, metabolism, and human health continues to be a central focus 27 of scientific inquiry. This Research Topic brings together a collection of eight distinct studies, each 28 shedding light on specific aspects of this complex interplay across diverse populations and 29 physiological contexts. From examining dietary trends and their association with obesity to 30 investigating the nuanced effects of different fatty acids and the impact of ultra-processed foods on 31 quality of life, these articles collectively highlight the elaborate nature of nutritional science and its 32 profound influence on well-being. 33 Alhusseini, et al., in